Skip to content

Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors

Application of 3D Printed Bone Prosthesis in Limb Salvage Surgery for Bone Tumors: a Single-center, Real-world Prospective Observational Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05616195
Enrollment
80
Registered
2022-11-15
Start date
2024-12-28
Completion date
2032-12-30
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Tumor

Brief summary

To report the patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital in the next 10 years, and collect the postoperative complications and limb function of these patients.

Detailed description

To report the patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. The basic data, treatment methods, postoperative complications and limb function of these patients were collected.

Interventions

OTHER3D printed bone prosthesis replacement surgery

To report the postoperative complications and limb function of patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital.

Sponsors

Henan Cancer Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Men and women of all ages are welcome. Pathologically confirmed in our hospital as a subtype of malignant tumor. He received 3D printed bone prosthesis replacement in our hospital.

Exclusion criteria

Not applicable.

Design outcomes

Primary

MeasureTime frameDescription
complicationsFrom surgery to 24 months after surgeryComplications were collected from patients who underwent 3D-printed bone prosthesis replacement surgery.
Limb functionPatients were enrolled until 24 months after surgeryLimb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026